Evaluation Study of SPOTme® Skin Cancer Screenings
| Status: | Enrolling by invitation |
|---|---|
| Conditions: | Skin Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 6/23/2018 |
| Start Date: | December 1, 2017 |
| End Date: | March 2019 |
This study evaluates the impact of the AAD SPOTme® skin cancer screening events on attendees'
skin cancer prevention and detection behaviors. This study will also evaluate whether an
educational intervention will improve post-screening engagement of attendees with
dermatologists.
skin cancer prevention and detection behaviors. This study will also evaluate whether an
educational intervention will improve post-screening engagement of attendees with
dermatologists.
Despite tremendous growth in both the interest and volume of skin cancer screenings at the
national level, the actual utility and impact of the AAD SPOT me™ skin cancer screening
programs have not been fully evaluated. This study will address this knowledge gap. Early
detection is vital in the fight against skin cancer, the most common cancer in the United
States. While the effects of skin cancer can be devastating, this disease is highly treatable
when detected early.
This study evaluates the impact of the AAD SPOTme® skin cancer screening events on attendees'
skin cancer prevention and detection behaviors. This study will also evaluate whether an
educational intervention will improve post-screening engagement of attendees with
dermatologists.
national level, the actual utility and impact of the AAD SPOT me™ skin cancer screening
programs have not been fully evaluated. This study will address this knowledge gap. Early
detection is vital in the fight against skin cancer, the most common cancer in the United
States. While the effects of skin cancer can be devastating, this disease is highly treatable
when detected early.
This study evaluates the impact of the AAD SPOTme® skin cancer screening events on attendees'
skin cancer prevention and detection behaviors. This study will also evaluate whether an
educational intervention will improve post-screening engagement of attendees with
dermatologists.
Inclusion Criteria:
- Participated in the American Academy of Dermatology national screening program in 2016
or 2017
- Have a presumptive diagnosis (screening, non-confirmed) of melanoma
- Have provided the AAD with permission to be re-contacted
- Have provided the AAD with an email address
- Aged 18 years or older
- Able to read English
Exclusion Criteria:
We found this trial at
1
site
Click here to add this to my saved trials
